PharmaCyte Biotech, Inc.
PMCB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001157075
No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in PharmaCyte Biotech, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −1 vs. Q4 2022
- Shares held
- 3.53M
- +136.0K (+4.0%) vs. Q4 2022
- Total value
- $10.2M
- +$288.8K (+2.9%) vs. Q4 2022
- New holders
- 5
- 6 more added
- Sold out
- 6
- 8 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMCB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $586.2K |
| Q1 2026 | 36 | $643.2K |
| Q4 2025 | 30 | $712.0K |
| Q3 2025 | 25 | $419.9K |
| Q2 2025 | 25 | $632.1K |
| Q1 2025 | 26 | $709.9K |
| Q4 2024 | 23 | $934.3K |
| Q3 2024 | 29 | $1.58M |
| Q2 2024 | 32 | $2.02M |
| Q1 2024 | 33 | $2.32M |
| Q4 2023 | 36 | $2.35M |
| Q3 2023 | 34 | $2.40M |
| Q2 2023 | 32 | $3.47M |
| Q1 2023 | 33 | $10.2M |
| Q4 2022 | 34 | $9.93M |
| Q3 2022 | 33 | $12.0M |
| Q2 2022 | 35 | $8.79M |
| Q1 2022 | 28 | $8.83M |
| Q4 2021 | 30 | $8.68M |
| Q3 2021 | 24 | $4.42M |
| Q2 2021 | 5 | $5.43K |
| Q1 2021 | 5 | $8.68K |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding PharmaCyte Biotech, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ayrton Capital LLC | 1,030,530 | $3.00M | 10.77% | −2,600−0.3% | Reduced |
| K2 Principal Fund, L.P. | 723,271 | $2.06M | 0.57% | −8,834−1.2% | Reduced |
| Vanguard Group Inc | 701,450 | $2.04M | 0.00% | +46,933+7.2% | Added |
| Equitec Proprietary Markets, LLC | 330,694 | $962.3K | 0.91% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 175,264 | $510.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 133,200 | $387.0K | 0.02% | +69,592+109.4% | Added |
| Susquehanna International Group, LLP | 106,886 | $311.0K | 0.00% | +106,886 | New |
| Citadel Advisors LLC | 76,011 | $221.2K | 0.00% | +58,508+334.3% | Added |
| State Street Corp | 62,600 | $182.2K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 43,711 | $127.2K | 0.00% | +31,727+264.7% | Added |
| Dimensional Fund Advisors LP | 29,303 | $85.3K | 0.00% | +29,303 | New |
| Northern Trust Corp | 29,248 | $85.1K | 0.00% | −8,371−22.3% | Reduced |
| Price T Rowe Associates Inc | 25,600 | $75.0K | 0.00% | −10,800−29.7% | Reduced |
| Schonfeld Strategic Advisors LLC | 24,000 | $69.8K | 0.00% | −1,200−4.8% | Reduced |
| Group One Trading, L.P. | 14,382 | $41.9K | 0.00% | +14,382 | New |
| Acadian Asset Management LLC | 9,264 | $26.0K | 0.00% | +9,264 | New |
| Belvedere Trading LLC | 7,135 | $20.8K | 0.01% | +7,135 | New |
| Advisor Group Holdings, Inc. | 1,758 | $5.12K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,688 | $4.91K | 0.00% | +1,679+18,655.6% | Added |
| Aspire Private Capital, LLC | 800 | $2.33K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 505 | $1.00K | 0.00% | +298+144.0% | Added |
| Kelly Financial Services LLC | 234 | $681 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 129 | $375 | 0.00% | −12−8.5% | Reduced |
| Advisory Services Network, LLC | 67 | $195 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 54 | $157 | 0.00% | −44−44.9% | Reduced |
| Morgan Stanley | 31 | $90 | 0.00% | −24−43.6% | Reduced |
| Anchor Investment Management, LLC | 27 | $79 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 3 | $9 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 2 | $6 | 0.00% | 00.0% | Unchanged |
| Carolina Wealth Advisors, LLC | 2 | $6 | 0.00% | 00.0% | Unchanged |
| Huntington National Bank | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 98 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Sabby Management, LLC | 0 | $0 | 0.00% | −97,978−100.0% | Sold out |
| Davy Global Fund Management Ltd | 0 | $0 | 0.00% | −40,800−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −31,100−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −20,705−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −17,219−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |